Can the Use of Bedside Lung Ultrasound Reduce Transmission Rates in The Case of The COVID-19 Patient? - A Narrative Review

Novel Corona Virus Disease-19 (nCov-19, COVID-19) was recognised as a pandemic by the World Health Organization on March 11, 2020. As of June 14, 2020, this contagious viral disease has afflicted 188 out of 195 countries in the world with 7,893,700 confirmed cases and 432,922 global deaths. Canada...

Full description

Bibliographic Details
Main Author: Sheena Bhimji-Hewitt
Format: Article
Language:English
Published: CINQUILL Medical Publishers Inc. 2020-07-01
Series:POCUS Journal
Online Access:https://ojs.library.queensu.ca/index.php/pocus/article/view/14227
_version_ 1798036952071536640
author Sheena Bhimji-Hewitt
author_facet Sheena Bhimji-Hewitt
author_sort Sheena Bhimji-Hewitt
collection DOAJ
description Novel Corona Virus Disease-19 (nCov-19, COVID-19) was recognised as a pandemic by the World Health Organization on March 11, 2020. As of June 14, 2020, this contagious viral disease has afflicted 188 out of 195 countries in the world with 7,893,700 confirmed cases and 432,922 global deaths. Canada has 98,787 people infected and 8,146 deaths. COVID-19 is thought to transmit through contact, droplets and aerosolization. A rapid review showed limited information on the benefits of conducting lung ultrasound (LUS) versus chest radiograph (CXR) or studies correlating lung ultrasound to chest computed Tomography (CT) in patients positive for Covid-19. The literature review confirmed that CT and LUS cannot diagnose this disease, but that both can help in the management and staging of this disease. There is no literature to prove that LUS at the bedside may be beneficial from the view of decreased transmission to other health care workers and bystanders due to reduced transit but comparing the transit pathway and contact leads one to propose that this would be so. Pregnant patients with COVID-19, young children and patients in the reproductive stage would also benefit from LUS since there is no radiation dose and the critical patient in distress will benefit from testing at the bedside.
first_indexed 2024-04-11T21:20:02Z
format Article
id doaj.art-09664797bf73479c97866e775182ad74
institution Directory Open Access Journal
issn 2369-8543
language English
last_indexed 2024-04-11T21:20:02Z
publishDate 2020-07-01
publisher CINQUILL Medical Publishers Inc.
record_format Article
series POCUS Journal
spelling doaj.art-09664797bf73479c97866e775182ad742022-12-22T04:02:39ZengCINQUILL Medical Publishers Inc.POCUS Journal2369-85432020-07-015110.24908/pocus.v5i1.14227Can the Use of Bedside Lung Ultrasound Reduce Transmission Rates in The Case of The COVID-19 Patient? - A Narrative ReviewSheena Bhimji-Hewitt0The Michener Institute of Education at UHN; Toronto, Ontario, Canada Novel Corona Virus Disease-19 (nCov-19, COVID-19) was recognised as a pandemic by the World Health Organization on March 11, 2020. As of June 14, 2020, this contagious viral disease has afflicted 188 out of 195 countries in the world with 7,893,700 confirmed cases and 432,922 global deaths. Canada has 98,787 people infected and 8,146 deaths. COVID-19 is thought to transmit through contact, droplets and aerosolization. A rapid review showed limited information on the benefits of conducting lung ultrasound (LUS) versus chest radiograph (CXR) or studies correlating lung ultrasound to chest computed Tomography (CT) in patients positive for Covid-19. The literature review confirmed that CT and LUS cannot diagnose this disease, but that both can help in the management and staging of this disease. There is no literature to prove that LUS at the bedside may be beneficial from the view of decreased transmission to other health care workers and bystanders due to reduced transit but comparing the transit pathway and contact leads one to propose that this would be so. Pregnant patients with COVID-19, young children and patients in the reproductive stage would also benefit from LUS since there is no radiation dose and the critical patient in distress will benefit from testing at the bedside. https://ojs.library.queensu.ca/index.php/pocus/article/view/14227
spellingShingle Sheena Bhimji-Hewitt
Can the Use of Bedside Lung Ultrasound Reduce Transmission Rates in The Case of The COVID-19 Patient? - A Narrative Review
POCUS Journal
title Can the Use of Bedside Lung Ultrasound Reduce Transmission Rates in The Case of The COVID-19 Patient? - A Narrative Review
title_full Can the Use of Bedside Lung Ultrasound Reduce Transmission Rates in The Case of The COVID-19 Patient? - A Narrative Review
title_fullStr Can the Use of Bedside Lung Ultrasound Reduce Transmission Rates in The Case of The COVID-19 Patient? - A Narrative Review
title_full_unstemmed Can the Use of Bedside Lung Ultrasound Reduce Transmission Rates in The Case of The COVID-19 Patient? - A Narrative Review
title_short Can the Use of Bedside Lung Ultrasound Reduce Transmission Rates in The Case of The COVID-19 Patient? - A Narrative Review
title_sort can the use of bedside lung ultrasound reduce transmission rates in the case of the covid 19 patient a narrative review
url https://ojs.library.queensu.ca/index.php/pocus/article/view/14227
work_keys_str_mv AT sheenabhimjihewitt cantheuseofbedsidelungultrasoundreducetransmissionratesinthecaseofthecovid19patientanarrativereview